Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes

Journal: Ther Adv Hematol

Publication date: 2023

Journal: Ther Adv Hematol

Publication Year: 2023

Authors & Co-authors: